UTHR
United Therapeutics Corporation · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang +6.7% ·
aliran saham -3.6% ·
posisi baru bersih +6.2%
· formula
Fragmentasi kepemilikan: lebih banyak pemegang, kepemilikan agregat yang lebih kecil.
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q1 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 86.02K | $43.82M | n/a | n/a |
| Q2 2026 | 157 | +4 | 27.98M | $15.17B | +8 | −5 |
| Q1 2026 | 157 | -1 | 29.64M | $17.54B | +5 | −7 |
| Q4 2025 | 157 | +1 | 32.29M | $15.72B | +2 | n/a |
| Q3 2025 | 21 | 0 | 20.11M | $8.43B | +1 | −2 |
| Q2 2025 | 19 | 0 | 20.17M | $5.79B | n/a | n/a |
| Q1 2025 | 16 | +1 | 10.14M | $3.12B | +1 | n/a |
| Q4 2024 | 15 | 0 | 10.52M | $3.71B | +1 | −1 |
| Q3 2024 | 14 | 0 | 8.99M | $3.22B | n/a | n/a |
| Q2 2024 | 14 | n/a | 8.17M | $2.60B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasif) | 2.23M | +1.4% | $687.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 2.11M | +0.8% | $649.52M | 1.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.03M | -17.8% | $624.68M | 0.1% | ▼ Trim | 4 | SEC ↗ ×9 |
| 4 | Geode Capital Management ✦ (pasif) | 1.22M | +7.5% | $377.24M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | AQR Capital Management ✦ | 908.45K | -6.9% | $273.31M | 0.3% | ▼ Trim | 4 | SEC ↗ ×4 |
| 6 | Norges Bank ✦ (pasif) | 466.35K | +8.4% | $143.76M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 398.23K | -26.6% | $122.76M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 8 | Marshall Wace ✦ | 213.00K | Baru | $65.66M | 0.1% | New | 1 | SEC ↗ ×3 |
| 9 | Bridgewater Associates ✦ | 193.78K | +79.9% | $59.74M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 189.73K | -52.3% | $58.49M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 11 | Gotham Asset Management ✦ | 89.34K | +46.0% | $27.54M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 36.18K | +77.9% | $11.15M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 30.27K | -30.1% | $9.33M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 14 | Fisher Asset Management ✦ | 18.59K | +13.8% | $5.73M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Millennium Management ✦ | 4.04K | -85.6% | $1.24M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 1.52K | -14.0% | $470,112 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Marshall Wace | $65.66M | 0.1% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 844 pemegang, 41.22M saham, $23.10B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer, Director · 401 lbr · $215,959
Officer, Director · 391 lbr · $212,185
Officer, Director · 40 lbr · $21,754
Officer, Director · 239 lbr · $128,964
Officer, Director · 535 lbr · $286,582
Officer, Director · 760 lbr · $408,681
Officer, Director · 1.02K lbr · $544,296
Officer, Director · 1.82K lbr · $969,579
Officer, Director · 240 lbr · $127,314
Officer, Director · 2.38K lbr · $1.27M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi